Facilitating Understanding in Informed Consent

Did you read the new draft Guidance from the FDA for Sponsors, Investigators, and IRBs on Key Information and Facilitating Informed Consent? Watch this webinar as our speaker discusses this guidance.

Action Steps for FDA Diversity Action Plans

In this webinar, industry experts offered examples of how diversity action plans vary among therapeutic areas — and why one size does not fit all. They also explained why it’s important to incorporate action plans earlier in the clinical trial process, as well as consequences for failing to follow a submitted plan.